Zepbound With Insurance: What You Will Actually Pay

Most commercially insured patients can lower their Zepbound prescription to as little as $25 per month by pairing their plan’s coverage with Lilly’s Zepbound Savings Card. When coverage is denied, the list price is $1,059.87 per four-pen carton, but Medicare’s new GLP-1 Bridge caps the cost at $50 a month for eligible Part D members. Your exact out-of-pocket cost depends on your deductible, copay or coinsurance tier, prior-authorization approval, and how quickly you hit your plan’s out-of-pocket maximum.

• Lilly’s Zepbound Savings Card lets commercially insured patients with coverage pay as little as $25 for a one-, two-, or three-month fill, with a $150 monthly and $1,800 annual savings cap.
• The nationwide list price for a 28-day supply of Zepbound is $1,059.87 before insurance. (investor.lilly.com)
• CVS Caremark will return Zepbound to its preferred commercial formularies on October 1, 2026, restoring coverage for millions of members. (cvshealth.com)
• Medicare’s GLP-1 Bridge demonstration lets eligible Part D beneficiaries obtain Wegovy or the Zepbound KwikPen for $50 a month starting July 1, 2026. (cms.gov)
• Plans that use coinsurance typically charge 15%-40% of the drug cost until the member reaches the annual out-of-pocket maximum; at the $1,059.87 list price, a 30% coinsurance equals about $318 a month.
• Zepbound prior authorizations often require a BMI ≥30 or ≥27 with a weight-related condition and proof of 5% weight loss by six months; quantity limits usually cap fills at four pens (one carton) per 28 days. (info.caremark.com)

Your Zepbound cost with insurance is usually a flat copay or a percentage coinsurance after any deductible.

When Zepbound Zepbound is on formulary, most employer and individual marketplace plans place it in a preferred or non-preferred brand tier.

Copay tiers: Some plans assign a fixed dollar amount-often $25-$150 per fill-for drugs in that tier. If your plan charges a $50 Tier 3 copay, your cost stays $50 even if the pharmacy’s claim total is higher.

Coinsurance tiers: Other plans use a percentage (15%-40% is common) of the drug’s allowed cost. With a 30% coinsurance, a $1,059.87 claim equals about $318 until you satisfy the plan’s annual out-of-pocket maximum.

Deductibles: High-deductible plans may require you to pay 100% of the allowed amount until you meet the deductible, then switch to the copay or coinsurance above.

💡 Why your cost can change mid-year

Once you hit your plan’s out-of-pocket maximum, most insurance companies pay 100% of covered drug costs for the rest of the year-so a $300 monthly bill can drop to $0 overnight.

Plans use deductibles, copays, coinsurance, and maximums to calculate your bill.

Every health plan relies on four levers that ultimately decide what you pay:

1. Deductible: The amount you must pay each year before the plan begins cost-sharing for brand drugs.

2. Copay or coinsurance: A flat fee or percentage that applies after the deductible.

3. Out-of-pocket maximum: A safety cap that stops cost-sharing once you reach it.

4. Prior authorization & quantity limits: Clinical rules the plan uses to approve or deny each refill (details next section).

Because GLP-1 medications such as Wegovy, Mounjaro, and Zepbound have list prices above $1,000, even a 15% coinsurance can exceed $150 per fill-much higher than a typical fixed copay. That is why the manufacturer savings programs are so valuable when coverage exists.

Most plans require prior authorization and cap Zepbound at one carton (four pens) every 28 days.

Formularies that cover Zepbound usually apply clinical criteria that mirror FDA labeling for chronic weight management.

Common PA checkpoints: body-mass index (BMI) of at least 30 kg/m², or 27 kg/m² plus a weight-related comorbidity; enrollment in a reduced-calorie diet and activity program; and documentation of at least 5% weight loss within six months to keep coverage active. Quantity limits published by CVS Caremark allow four pens per 21-28 days and twelve pens per 63-84 days, depending on the fill period. (info.caremark.com)

If your PA is rejected, appeal rights vary by state and by plan, but you typically have at least one internal and one external review level. For step-by-step instructions, see our prior-authorization appeal guide.

Pairing insurance with the Zepbound Savings Card drops the bill to $25 for most people.

The Zepbound Savings Card is the fastest way to lower your cost once coverage is in place.

To qualify, you must have commercial insurance that already covers the drug, and you cannot combine the card with another coupon or discount.

Medicare’s GLP-1 Bridge caps Zepbound at $50 a month, while Medicaid cost-sharing is usually under $15.

The Inflation Reduction Act authorized CMS to test expanded GLP-1 access. Beginning July 1, 2026, eligible Part D beneficiaries can fill the Zepbound KwikPen or any Wegovy formulation for $50 per month through the Medicare GLP-1 Bridge. (cms.gov) Standard Part D still charges 25% coinsurance for covered brand drugs, so the Bridge can cut monthly costs by hundreds of dollars. (cms.gov)

State Medicaid programs have wide discretion but typically charge a nominal copay-often $5-$11 for GLP-1 agents. (mounjaro.lilly.com) Coverage may still require PA and evidence of weight-related comorbidities.

Denied coverage? Follow these four appeal steps.

Insurers must give you written reasons for a PA denial. Here is how to respond:

1. Request the full denial letter: It outlines the clinical criteria you need to address.

2. Gather supporting documents: Most appeals succeed when you provide BMI records, chart notes, and a letter of medical necessity.

3. Submit the internal appeal: Plans must review it within 30 days (sooner for urgent requests).

4. Escalate to external review if needed: Independent reviewers can overturn the decision if your case meets medical-necessity standards. See our full coverage guide for templates.

Lower-cost options when insurance coverage falls through

If you do not yet qualify for coverage-or you have already exhausted savings caps-two non-insurance routes may help.

LillyDirect self-pay pricing: Lilly sells Zepbound directly to consumers and through partnered pharmacies at discounted “self-pay” rates. Current prices range from $299 to $699 per carton depending on dose. (zepbound.lilly.com) The program cannot be combined with insurance or the savings card.

⚠️ Check local prices before you pay cash

Drug prices can vary widely between pharmacies. Use Rx.com’s free discount card to compare cash prices before you swipe your insurance card or savings card.